Cargando…

Effectiveness of the live zoster vaccine during the 10 years following vaccination: real world cohort study using electronic health records

OBJECTIVES: To assess the effectiveness of live zoster vaccine during more than 10 years after vaccination; and to describe methods for ascertaining vaccine effectiveness in the context of waning. DESIGN: Real world cohort study using electronic health records. SETTING: Kaiser Permanente Northern Ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klein, Nicola P, Bartlett, Joan, Fireman, Bruce, Marks, Morgan A, Hansen, John, Lewis, Edwin, Aukes, Laurie, Saddier, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630909/ https://www.ncbi.nlm.nih.gov/pubmed/37940142 http://dx.doi.org/10.1136/bmj-2023-076321

Ejemplares similares

Effectiveness of Live Zoster Vaccine in Preventing Herpes Zoster Ophthalmicus (HZO)
por: Aukes, Laurie, et al.
Publicado: (2017)

2481. Impact of Sex and Race/Ethnicity on the Effectiveness of Live Zoster Vaccine
por: Marks, Morgan A, et al.
Publicado: (2018)

Long-Term Effectiveness of the Live Zoster Vaccine in Preventing Shingles: A Cohort Study
por: Baxter, Roger, et al.
Publicado: (2018)

1047 Use of electronic data to identify new zoster cases for a vaccine effectiveness study
por: Baxter, Roger, et al.
Publicado: (2014)

22. An Innovative Approach to Examining the Waning of Vaccine Effectiveness Using Automated Healthcare Data
por: Aukes, Laurie, et al.
Publicado: (2021)

2480. Real-World Effectiveness of the Live Zoster Vaccine in Preventing Herpes Zoster: A Systematic Review
por: Saddier, Patricia, et al.
Publicado: (2018)

Use of Electronic Data to Identify Risk Factors Associated with Clostridium difficile Infection (CDI) and to Develop CDI Risk Scores
por: Aukes, Laurie, et al.
Publicado: (2017)

A Risk Score to Predict Clostridioides difficile Infection
por: Aukes, Laurie, et al.
Publicado: (2021)

2322. Effectiveness of Recombinant Influenza Vaccine vs. Standard Dose Inactivated Influenza Vaccines Against Hospitalized Influenza-Related Outcomes in Adults: A Cluster Randomized Trial
por: Hsiao, Amber, et al.
Publicado: (2022)

Effectiveness and safety of recombinant zoster vaccine: A review of real-world evidence
por: Parikh, Raunak, et al.
Publicado: (2023)

Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination
por: Hansen, John, et al.
Publicado: (2021)

5. Observational Study of Routine Use of 9-Valent Human Papillomavirus Vaccine: Safe in More Than 140,000 Individuals
por: Hansen, John, et al.
Publicado: (2020)

The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine
por: Dagnew, Alemnew F, et al.
Publicado: (2020)

Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study
por: Amend, Kandace L., et al.
Publicado: (2022)

Live Attenuated Influenza Vaccination Before 3 Years of Age and Subsequent Development of Asthma: A 14-year Follow-up Study
por: Baxter, Roger P., et al.
Publicado: (2018)

Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine
por: Grupping, Katrijn, et al.
Publicado: (2017)

Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season
por: Klein, Nicola P., et al.
Publicado: (2020)

LB15. Vaccine Effectiveness of Flucelvax Relative to Inactivated Influenza Vaccine During the 2017–18 Influenza Season in Northern California
por: Klein, Nicola P, et al.
Publicado: (2018)

Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data
por: Nelson, Jennifer C, et al.
Publicado: (2022)

1105 Chronic Kidney Disease and Invasive Pneumococcal Disease in Adults
por: Baxter, Roger, et al.
Publicado: (2014)

Real-World Effectiveness and Safety of a Live-Attenuated Herpes Zoster Vaccine: A Comprehensive Review
por: Ansaldi, Filippo, et al.
Publicado: (2016)

1156. Real-World Effectiveness of Recombinant Zoster Vaccine in Chinese Adults Aged ≥50 Years in the US
por: Florea, Ana, et al.
Publicado: (2023)

Herpes Zoster Following Recombinant Zoster Vaccine With or Without Concomitant Vaccination
por: Bruxvoort, Katia J, et al.
Publicado: (2022)

Herpes Zoster Vaccination
por: Kim, Kyung Hoon
Publicado: (2013)

Herpes Zoster Vaccines
por: Harbecke, Ruth, et al.
Publicado: (2021)

Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact model
por: Patterson, Brandon J, et al.
Publicado: (2020)

Maternal SARS-CoV-2 Vaccination and Infant Protection Against SARS-CoV-2 During the First 6 Months of Life
por: Zerbo, Ousseny, et al.
Publicado: (2022)

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: A Phase III, Group-Matched, Clinical Trial
por: Grupping, Katrijn, et al.
Publicado: (2017)

Influenza Vaccination and Mortality: Differentiating Vaccine Effects From Bias
por: Fireman, Bruce, et al.
Publicado: (2009)

Preventing Varicella-Zoster: Advances With the Recombinant Zoster Vaccine
por: Ilyas, Sahrish, et al.
Publicado: (2020)

2297. COVID-19 Vaccine Effectiveness Among Pregnant People
por: Zerbo, Ousseny, et al.
Publicado: (2022)

Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live
por: Curran, Desmond, et al.
Publicado: (2019)

Real‐world evidence from over one million COVID‐19 vaccinations is consistent with reactivation of the varicella‐zoster virus
por: Hertel, M., et al.
Publicado: (2022)

Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 during the first six months of life
por: Zerbo, Ousseny, et al.
Publicado: (2023)

Herpes zoster vaccine in Korea
por: Choi, Won Suk
Publicado: (2013)

Vaccine against herpes zoster
por: Pasternak, Jacyr
Publicado: (2013)

Healthy ageing: Herpes zoster infection and the role of zoster vaccination
por: Curran, Desmond, et al.
Publicado: (2023)

Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease After Introduction Into Routine Pediatric Use
por: Baxter, Roger, et al.
Publicado: (2020)

1078 Risk Factors Associated with Developing Fever Following First Dose Measles-Containing Vaccines
por: Klein, Nicola P., et al.
Publicado: (2014)

Herpes zoster following COVID-19 vaccination in an immunocompetent and vaccinated for herpes zoster adult: A two-vaccine related event?
por: Vallianou, Natalia G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mr519i6vp0sbl04ku1qu01nmcj